Welnfuse forms advisory council
By HME News Staff
Updated 11:16 AM CDT, Tue April 25, 2023
DALLAS – Welnfuse, a software and technology platform for infusion therapy and medication delivery in the United States, has established the Infusion Technology Advisory Council (ITAC). The council assembles industry leaders from the infusion center, home infusion, specialty pharmacy and health care technology sectors to support the company’s continued growth and expansion. "We are very excited to welcome this group of renowned industry leaders from across the nation," said Bryan Johnson, co-founder and CEO of Welnfuse. "This team of infusion and technology professionals will help guide, educate and advance WeInfuse's efforts in the industry to provide the most innovative, capable and user-friendly solution possible." Johnson and Reece Norris, co-founder and COO, will lead ITAC and serve as its co-chairmen. Michael Dal Bello and Ceron Rhee, WeInfuse board members and partners at Curewell Capital, will also join ITAC. Other inaugural board members include Jeff Johnston, co-founder and former CEO of CPR+; George Lazenby, former CEO of Emdeon (now Change Healthcare/Optum); Rob Allen, former president of Coram CVS Specialty Infusion Services; Dan Teich, PharmD, vice president at AmerisourceBergen; and Cannon Loughry, COO of TwelveStone Health Partners.
Comments